Wedbush Securities Inc. Reduces Stock Holdings in Oracle Corporation $ORCL

Wedbush Securities Inc. lessened its stake in shares of Oracle Corporation (NYSE:ORCL) by 7.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 52,669 shares of the enterprise software provider’s stock after selling 4,425 shares during the quarter. Oracle makes up approximately 0.5% of Wedbush Securities Inc.’s investment portfolio, making the stock its 27th biggest holding. Wedbush Securities Inc.’s holdings in Oracle were worth $14,813,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of ORCL. Brighton Jones LLC raised its position in Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after purchasing an additional 100,494 shares during the period. Revolve Wealth Partners LLC grew its stake in shares of Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after buying an additional 404 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Oracle by 21.5% in the second quarter. Sivia Capital Partners LLC now owns 4,348 shares of the enterprise software provider’s stock worth $951,000 after buying an additional 768 shares during the period. Moran Wealth Management LLC lifted its stake in shares of Oracle by 19.6% during the 2nd quarter. Moran Wealth Management LLC now owns 14,369 shares of the enterprise software provider’s stock worth $3,141,000 after acquiring an additional 2,358 shares during the last quarter. Finally, Aries Wealth Management boosted its holdings in Oracle by 2.6% during the 2nd quarter. Aries Wealth Management now owns 6,881 shares of the enterprise software provider’s stock valued at $1,504,000 after acquiring an additional 175 shares during the period. 42.44% of the stock is currently owned by institutional investors.

Oracle Trading Down 1.7%

Shares of NYSE:ORCL opened at $157.18 on Thursday. The company has a market capitalization of $451.61 billion, a PE ratio of 29.55, a P/E/G ratio of 1.40 and a beta of 1.64. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The business’s fifty day simple moving average is $186.04 and its 200-day simple moving average is $232.32.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The firm had revenue of $16.06 billion during the quarter, compared to analysts’ expectations of $16.19 billion. During the same period in the prior year, the business posted $1.47 EPS. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. As a group, equities research analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 23rd. Stockholders of record on Friday, January 9th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Friday, January 9th. Oracle’s dividend payout ratio (DPR) is currently 37.59%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on ORCL shares. JPMorgan Chase & Co. reduced their target price on Oracle from $270.00 to $230.00 and set a “neutral” rating on the stock in a research note on Thursday, December 11th. Wells Fargo & Company began coverage on shares of Oracle in a report on Wednesday, December 3rd. They set an “overweight” rating and a $280.00 price objective for the company. JMP Securities restated a “market outperform” rating and issued a $342.00 target price on shares of Oracle in a research note on Friday, October 17th. Barclays reaffirmed an “overweight” rating on shares of Oracle in a research report on Monday, February 2nd. Finally, Morgan Stanley lowered their price target on Oracle from $320.00 to $213.00 and set an “equal weight” rating for the company in a report on Friday, January 23rd. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Oracle presently has a consensus rating of “Moderate Buy” and a consensus price target of $292.43.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: CMS selected Oracle Cloud Infrastructure (OCI) to support its modernization initiative — a material, mission‑critical federal win that can generate multi‑year, sticky cloud revenue and strengthen OCI’s credibility with other large public‑sector customers. Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid’s Modernization Initiative
• Positive Sentiment: Product & commercial traction in healthcare — Oracle Health’s Clinical AI Agent (now available in the U.K.) and new customer wins (e.g., Hillsboro Health) demonstrate adoption of AI documentation and EHR migrations that can boost SaaS/cloud revenue and RPO. Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care
• Positive Sentiment: AI product momentum — Oracle rolled out AI agents for Fusion Apps and other Fusion enhancements (no‑cost deployment claims), reinforcing the company’s SaaS/cloud growth narrative. Oracle Unveils AI Agents for Fusion Apps
• Neutral Sentiment: OpenAI/AI linkage remains a sentiment driver — renewed optimism about Oracle’s exposure to OpenAI and AI infrastructure can lift sentiment but is speculative and dependent on partner outcomes. Oracle gets fresh boost from optimism around OpenAI exposure
• Neutral Sentiment: Short‑squeeze/volatility chatter: sector headlines (Barron’s, others) and elevated short interest mean ORCL can see amplified moves both higher (short‑covering) and lower (continued selling). Software Stocks Look Primed for a Short Squeeze
• Negative Sentiment: Legal overhang: multiple securities‑class action filings covering June–December 2025 introduce litigation risk and uncertainty that can pressure the stock and increase potential liabilities. Oracle Sued for Securities Law Violations
• Negative Sentiment: Insider selling: CEO Clayton Magouyrk sold 10,000 shares (~$1.55M). Single insider sales can be benign, but markets often view CEO sales as a negative signal if timed near other headwinds. SEC Form 4 — Clayton M. Magouyrk sale
• Negative Sentiment: Analyst revisions & guidance risk: Scotiabank trimmed FY2027 EPS forecasts (from $6.48 to $6.28), and some firms have downgraded or lowered targets amid scrutiny over AI monetization and Oracle’s leverage — these cuts can cap near‑term upside.

Insider Activity

In related news, CEO Clayton M. Magouyrk sold 10,000 shares of the stock in a transaction that occurred on Monday, February 9th. The shares were sold at an average price of $155.23, for a total transaction of $1,552,300.00. Following the completion of the sale, the chief executive officer owned 134,030 shares of the company’s stock, valued at $20,805,476.90. This represents a 6.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Mark Hura sold 15,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $196.89, for a total transaction of $2,953,350.00. Following the completion of the sale, the insider owned 234,077 shares of the company’s stock, valued at approximately $46,087,420.53. This trade represents a 6.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 72,223 shares of company stock worth $13,689,064 in the last quarter. 40.90% of the stock is currently owned by corporate insiders.

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.